Rescue therapy in methotrexate toxicity: case report
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20232549Keywords:
Drug toxicity, Erythematous plaques, Filgrastim, MTXAbstract
Methotrexate (MTX) is widely used for the treatment of psoriasis. It has an antiproliferative action by inhibiting dihydrofolate reductase enzyme, therefore interferes with folic acid synthesis. MTX toxicity is rarely reported and the most common cause of it is accidental overdosage by the patient. This is a case report of a 51-year-old male, a known case of psoriasis, who presented with multiple erythematous tender plaques associated with burning sensation. He self-medicated with tablet MTX 5 mg daily for 10 days when the lesions got exacerbated and was found to be leucopenic. On skin biopsy, diagnosis of psoriasis with MTX induced epidermal necrolysis was established. Patient was treated with filgrastim 300 μg which was given subcutaneously 1 day apart. On follow up, lesions subsided and repeat counts were within normal limits. Patients should be explained about the selected treatment regime and discouraged from self-medicating.
Metrics
References
Fridlington JL, Tripple JW, Reichenberg JS, Hall CS, Diven DG. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue. Dermatol Online J. 2011;17(11).
Caliskan E, Tunca M, Açikgöz G, Arca E, Akar A. Accidental high-dose methotrexate toxicity due to an electronic prescribing error. Indian J Dermatol Venereol Leprol. 2014;80:268.
Agarwal KK, Nath AK, Thappa DM. Methotrexate toxicity presenting as ulceration of psoriatic plaques: a report of two cases. Indian J Dermatol, Venereol Leprol. 2008;74:481.
Pearce HP, Wilson BB. Erosion of psoriatic plaques: an early sign of methotrexate toxicity. J Am Academy Dermatol. 1996;35(5):835-8.
Chavan RB, Belgaumkar V, Gosavi AP, Deshmukh NS, Bhatt N, Agrawal K. Mucocutaneous ulcerations as a first sign of methotrexate toxicity. Dermatol Rev/ Przegląd Dermatologiczny. 2012;108(1):74-6.
Madke B, Singh AL. Acute methotrexate toxicity. Indian J Drugs Dermatol. 2015;1(1):46.
BTG International, Inc. Voraxaze (glucarpidase) intravenous injection, product information. West Conshohocken, PA: BTG International, Inc. 2013.
Paul C, Cather J, Gooderham M, Poulin Y, Mrowietz U, Ferrandiz C et al. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2). Brit J Dermatol. 2015;173(6):1387-99.
